Global WholeHealth Partners, Corp (GWHP: OTC) Announces the Beginning Research for Saliva COVID 19 SARS 2 Antigen (N+S) Tests
Dr. Shujie Cui has developed a (N+S) Antigen test with great sensitivity and is planning to create the first Saliva N+S Antigen Test San Clemente, CA, Jan. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Mr. Strongo, CEO of Global WholeHealth Partners …